Publications
Found 4 results
Filters: Author is T. Guo [Clear All Filters]
“Cloning and expression of the sucrose transporter gene PsSUT1 from tree peony leaf”, vol. 14, pp. 12406-12415, 2015.
, “Shock wave treatment enhances endothelial proliferation via autocrine vascular endothelial growth factor”, vol. 14, pp. 19203-19210, 2015.
, “Genetic variations of ISL1 associated with human congenital heart disease in Chinese Han people”, vol. 13, pp. 1329-1338, 2014.
, “Association between interleukin 21 and Graves’ disease”, vol. 10, pp. 3338-3346, 2011.
,
Bahn RS (1995). Assessment and management of the patient with Graves' ophthalmopathy. Endocr. Pract. 1: 172-178.
PMid:15251590
Ban Y and Tomer Y (2003). The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379.
http://dx.doi.org/10.1080/08916930310001603037
PMid:14669944
Barrett JC, Fry B, Maller J and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
http://dx.doi.org/10.1093/bioinformatics/bth457
PMid:15297300
Bednarczuk T, Gopinath B, Ploski R and Wall JR (2007). Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin. Endocrinol. 67: 3-19.
http://dx.doi.org/10.1111/j.1365-2265.2007.02854.x
PMid:17521325
Caprioli F, Sarra M, Caruso R, Stolfi C, et al. (2008). Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180: 1800-1807.
PMid:18209077
Caruso R, Fina D, Peluso I, Fantini MC, et al. (2007). IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J. Immunol. 178: 5957-5965.
PMid:17442980
Chen RH, Chen WC, Chang CT, Tsai CH, et al. (2005). Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J. Clin. Lab. Anal. 19: 133-138.
http://dx.doi.org/10.1002/jcla.20067
PMid:16025481
Davis ID, Skak K, Smyth MJ, Kristjansen PE, et al. (2007). Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res. 13: 6926-6932.
http://dx.doi.org/10.1158/1078-0432.CCR-07-1238
PMid:18056166
Farid NR and Balazs C (1998). The genetics of thyroid associated ophthalmopathy. Thyroid 8: 407-409.
http://dx.doi.org/10.1089/thy.1998.8.407
PMid:9623731
Hiromatsu Y, Kaku H, Miyake I, Murayama S, et al. (2002). Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12: 217-221.
http://dx.doi.org/10.1089/105072502753600160
PMid:11952042
Hiromatsu Y, Mukai T, Kaku H, Miyake I, et al. (2006). IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabet. Med. 23: 211-215.
http://dx.doi.org/10.1111/j.1464-5491.2005.01734.x
PMid:16433722
Kasaian MT, Whitters MJ, Carter LL, Lowe LD, et al. (2002). IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569.
http://dx.doi.org/10.1016/S1074-7613(02)00295-9
Leonard WJ and Spolski R (2005). Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5: 688-698.
http://dx.doi.org/10.1038/nri1688
PMid:16138102
Liang J, Chen P, Hu Z, Zhou X, et al. (2008). Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29: 2341-2346.
http://dx.doi.org/10.1093/carcin/bgn235
PMid:18845558
Lin MC, Hsu FM, Bee YS and Ger LP (2008). Age influences the severity of Graves' ophthalmopathy. Kaohsiung J. Med. Sci. 24: 283-288.
http://dx.doi.org/10.1016/S1607-551X(08)70154-2
Liu R, Van KL, La CA, Price M, et al. (2006). Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol. 176: 5247-5254.
PMid:16621990
Liu Y, Helms C, Liao W, Zaba LC, et al. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4: e1000041.
http://dx.doi.org/10.1371/journal.pgen.1000041
PMid:18369459 PMCid:2274885
Mehta DS, Wurster AL and Grusby MJ (2004). Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202: 84-95.
http://dx.doi.org/10.1111/j.0105-2896.2004.00201.x
PMid:15546387
Meller J, Jauho A, Hufner M, Gratz S, et al. (2000). Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 10: 1073-1079.
http://dx.doi.org/10.1089/thy.2000.10.1073
PMid:11201852
Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, et al. (1989). Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73: 639-644.
http://dx.doi.org/10.1136/bjo.73.8.639
PMid:2765444 PMCid:1041835
Ozaki K, Spolski R, Feng CG, Qi CF, et al. (2002). A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
http://dx.doi.org/10.1126/science.1077002
PMid:12446913
Parrish-Novak J, Dillon SR, Nelson A, Hammond A, et al. (2000). Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
http://dx.doi.org/10.1038/35040504
PMid:11081504
Piao WH, Jee YH, Liu RL, Coons SW, et al. (2008). IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 67: 37-46.
http://dx.doi.org/10.1111/j.1365-3083.2007.02035.x
PMid:18052963
Solé X, Guinó E, Valls J, Iniesta R, et al. (2006). SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929.
http://dx.doi.org/10.1093/bioinformatics/btl268
PMid:16720584
Spolski R and Leonard WJ (2008a). Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-79.
http://dx.doi.org/10.1146/annurev.immunol.26.021607.090316
PMid:17953510
Spolski R and Leonard WJ (2008b). The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 20: 295-301.
http://dx.doi.org/10.1016/j.coi.2008.02.004
PMid:18554883 PMCid:2546604
Strengell M, Matikainen S, Siren J, Lehtonen A, et al. (2003). IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170: 5464-5469.
PMid:12759422
Vollmer TL, Liu R, Price M, Rhodes S, et al. (2005). Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 174: 2696-2701.
PMid:15728477
Wall JR, Salvi M, Bernard NF, Boucher A, et al. (1991). Thyroid-associated ophthalmopathy - a model for the association of organ-specific autoimmune disorders. Immunol. Today 12: 150-153.
PMid:1878126
Weetman AP, Cohen S, Gatter KC, Fells P, et al. (1989). Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin. Exp. Immunol. 75: 222-227.
PMid:2784734 PMCid:1542121
Yamada M, Li AW and Wall JR (2000). Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit. Rev. Clin. Lab. Sci. 37: 523-549.
http://dx.doi.org/10.1080/10408360091174303
PMid:11192331